Company Insights

ABXL customer relationships

Explore interactive graphBrowse insights index
ABXL customer relationship map

ABXL customer relationships: what investors need to know

ABXL operates a mix of asset management, life-settlements origination and servicing, and newly launched technology services that monetize through fixed annual contracts, asset-based fees, and trading/spread income on life insurance policies. Revenue comes from three clear levers: fee-based services to institutions and intermediaries, asset-management fees tied to assets under management, and transactional profit from buying and selling policies. The FY2024 10‑K lists two named related-party customer relationships that are relevant for governance and counterparty risk assessment. For a deeper profile of counterparties and operating constraints, review ABXL’s public filing and third-party coverage at https://nullexposure.com/.

If you are screening counterparties or evaluating concentration, begin with the company filing and corroborating market reports: https://nullexposure.com/.

What the SEC filing actually lists — named related parties

ABXL’s FY2024 Form 10‑K discloses two related‑party customer relationships. Each is short and explicit in the filing.

Nova Holding (US) LP

Abacus Settlements has a related‑party relationship with Nova Holding (US) LP, as disclosed in ABXL’s FY2024 10‑K. This listing flags potential governance or affiliated‑counterparty considerations for investors assessing related‑party revenue or balance‑sheet exposure (10‑K, FY2024).

Nova Trading (US), LLC

Abacus Settlements also has a related‑party relationship with Nova Trading (US), LLC, per the same FY2024 10‑K. The presence of an entity with “Trading” in its name suggests transactional counterparty interaction—important for analyzing trading revenue and conflict‑of‑interest controls (10‑K, FY2024).

How the relationships fit into ABXL’s operating model

The filing frames ABXL as a multi-segment operator: Originations, Portfolio Servicing, Asset Management, and a nascent Technology Services arm (operating under ABL Technologies, LLC). From the disclosure set, investors should internalize several company-level signals that define contract structure, client composition and maturity.

  • Contracting posture: Technology Services are sold on fixed annual contracts with subscription-like characteristics; asset management fees are percentage-based and therefore usage/scale sensitive. The filing explicitly states Technology Services fees are fixed annual contracts and asset management fees are based on assets under management (10‑K, FY2024).
  • Counterparty mix and criticality: The business serves pension funds, government agencies, insurance businesses, institutional investors and individual channels (financial advisors, direct-to-consumer, intermediaries) — a mix that makes some revenue streams mission‑critical for counterparties (e.g., mortality verification for government/pension clients) while other revenues are more retail/intermediary driven.
  • Geographic footprint: Operations are primarily U.S. (49 states + DC), with a modest EMEA footprint via a Luxembourg office for Asset Management — enough to imply regional regulatory exposure and some cross-jurisdiction operational complexity.
  • Service versus product: The company is primarily a services business, with asset management and servicing as core lines and a small software/technology component (ABL Tech) that is ramping.
  • Maturity and ramping signals: ABXL reports leadership in life settlements with an asserted ~26% market share by capital invested (2023 basis), which positions parts of the business as mature, while Technology Services is new (first revenue recognized Dec 2024; $33,628 in 2024) and therefore in a ramp phase (10‑K, FY2024).

These operating characteristics inform valuation sensitivity: recurring annual contracts and AUM-linked fees provide predictable cashflow tails, while trading and origination profits inject earnings volatility.

Midway through diligence, pull the filing and supporting materials on governance and counterparty limits at https://nullexposure.com/.

Relationship roles and implications for investors

The filing and segment discussion portray ABXL operating in two complementary roles with counterparties: as a seller/trader of life‑insurance assets (originations and active trading) and as a service provider (portfolio servicing, actuarial and technology services).

  • Seller / Trading counterparty exposure: The company buys policies and either trades them to institutional investors or holds them to maturity, generating spread and mark‑to‑market effects. This trading posture requires strong counterparty controls and clear related‑party disclosure, especially given the Nova relationships named in the 10‑K (10‑K, FY2024).
  • Service provider criticality: Technology Services deliver real‑time mortality verification and missing‑participant checks to pension funds and government agencies — services that are operationally critical for customers and therefore a concentration risk if a small number of large clients account for a disproportionate share of fees (10‑K, FY2024).

Risk factors and what to watch next

Investors should prioritize three practical checks when evaluating ABXL counterparties and the named Nova relationships:

  1. Related‑party governance: The 10‑K’s explicit naming of Nova Holding (US) LP and Nova Trading (US), LLC requires review of transaction terms, pricing, and board oversight to rule out preferential dealing or contingent liabilities (10‑K, FY2024).
  2. Client concentration and contract structure: Fixed annual contracts with governments and pension funds increase revenue predictability but concentrate counterparty risk; asset‑based fees expose the company to market and redemption risk in downturns (10‑K, FY2024).
  3. Technology ramp and scale economics: Technology Services are nascent (first revenue Dec 2024; $33,628 for the year), so scale economics, customer adoption across public sector and institutional clients, and contract renewals will determine whether the software line becomes a material margin driver (10‑K, FY2024).

Bottom line and next steps for analysts

ABXL combines a stable fee base with procedurally risky trading activity; the FY2024 10‑K names Nova Holding (US) LP and Nova Trading (US), LLC as related‑party counterparts, a disclosure that raises governance and counterparty‑exposure questions worth immediate follow‑up. Investors should prioritize review of related‑party transaction schedules, client concentration metrics, and the commercialization plan for Technology Services.

For a structured diligence pack and ongoing monitoring of ABXL’s counterparty exposures, start with the company filing and additional intelligence at https://nullexposure.com/.

If you’d like a tailored watchlist or a concise memo that flags the specific clauses and numbers in ABXL’s 10‑K, request a briefing through our homepage: https://nullexposure.com/.